[1] PubMed ID: | 35433983 |
Disease Name: | pancreatic ductal adenocarcinoma |
Sample: | PDAC tissues and cells |
Dysfunction Pattern: | Interaction(miR-19a-3p/TBK1/MAPK axis) |
Validated Method: | qRT-PCR//Luciferase Report Assay//IHC//EdU Staining |
Description: | Our data showed that LINC00483 was significantly upregulated in PDAC compared to normal tissue. Subsequently, we found that miR-19a-3p binds to TBK1 in PDAC and LINC00483 could regulate PDAC cell progression by regulating miR-19a-3p via the TBK1/MAPK pathway. |
Causality: | Yes |
Causal Description: | LINC00483 suppression inhibited proliferation and invasion in vitro and tumor development in vivo via modulation of miR-19a-3p expression. |
Clinical-realted Application: | High level of LINC00483 was correlated with advanced clinical stage, tumor invasion and metastasis, and adverse prognosis in PDAC patients. |